Aspirin PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering a Aspirin PCD pharma franchise across India. Our portfolio spans 23 Aspirin formulations in Capsule and Tablet forms, backed by consistent quality and monopoly-based distribution rights for our franchise partners.

What is Aspirin?

Aspirin (acetylsalicylic acid) irreversibly inhibits the cyclo-oxygenase enzyme, reducing the formation of prostaglandins and thromboxane. At low doses this makes it a potent antiplatelet agent that helps prevent clot formation, while higher doses provide analgesic, anti-inflammatory and antipyretic effects. Its profile is documented on PubChem.

Therapeutic Applications

Low-dose aspirin is used for the secondary prevention of heart attack and stroke and in acute coronary syndromes, frequently in fixed-dose combinations with clopidogrel, atorvastatin or rosuvastatin. Higher doses relieve pain, fever and inflammation. It is prescribed by cardiologists, physicians and neurologists.

Why Aspirin is a High-Potential Molecule for Distributors

Low-dose aspirin is a lifelong cornerstone of cardiovascular prevention, and with cardiac disease rising steadily across India its patient base grows year on year. Enteric-coated and combination formats — aspirin with a statin or an antiplatelet — create premium, high-margin SKUs around a low-cost base molecule. Because therapy is chronic and daily, a distributor gains highly predictable repeat demand within a broader cardio-diabetic range. With 23 formulations, it anchors a complete cardiac basket.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district and state-wise monopoly rights, WHO-GMP certified and DCGI-approved manufacturing, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent supply and billing model helps you build a profitable, protected business in your territory.

References

1. PubChem — Aspirin
2. MedlinePlus — Blood Thinners
3. PubMed — Aspirin literature